Targeting tuberculosis infection in macrophages using chitosan oligosaccharide nanoplexes
- 40 Downloads
Targeting bacterial infections using RNA interference (RNAi) has been a relatively nascent area of research as compared with cancer and viral infections. Exploring this area is especially vital due to the prevalence of numerous challenging bacterial infections that have been persistent despite treatment with antibiotics or antibiotic-loaded delivery systems. In this investigation, we formulate siRNA nanoparticle complexes, using cationic water-soluble chitosan polymer, for intracellular delivery into macrophages that serve as reservoirs of numerous pathogenic bacteria, including Mycobacterium tuberculosis (Mtb). Cationic chitosan oligosaccharide nanoparticles of size 215.3 ± 4.19 nm were formulated by ionotropic gelation and were effectively delivered along with siRNA into the macrophages, without any obvious cytotoxicity. The siRNA-loaded nanoparticles resulted in more than two-fold down-regulation of the host gene, Bfl1/A1, as compared with untreated controls. Since the over expression of host gene Bfl1/A1 favours for survival of Mtb within macrophages, the nanoparticles present a promising potential for developing anti-tuberculosis therapy.
KeywordsMycobacteria Bfl-1/a1 siRNA delivery Chitosan oligosaccharides Macrophages Nanomedicine
Mr. Uday Koli was financially supported by the Department of Biotechnology (BT/PR5372/MED/29/489/2012), Govt. of India and the Department of Atomic Energy (DAE: 2012/20/37B/08/BRNS) for fellowship. Dr. Prajakta Dandekar was financially supported by the Ramanujan Fellowship Grant (SR/S2/RJN-139/2011), DST, Govt. of India. Dr. Ratnesh Jain was financially supported by the Ramalingaswami Fellowship (BT/RLF/RE-ENTRY/51/2011), DBT, Govt. of India.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Abed N, Saïd-Hassane F, Zouhiri F, Mougin J, Nicolas V, Desmaële D, Gref R, Couvreur P (2015) An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Sci Rep 5Google Scholar
- Alexandru-Flaviu T, Cornel C (2014) Macrophages targeted drug delivery as a key therapy in infectious disease. BMBN 2(1):17–20Google Scholar
- Clemens DL, Lee B-Y, Xue M, Thomas CR, Meng H, Ferris D, Nel AE, Zink JI, Horwitz MA (2012) Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob Agents Chemother 56(5):2535–2545CrossRefGoogle Scholar
- Hadwiger L, Kendra D et al (1986) Chitosan both activates genes in plants and inhibits RNA synthesis in fungi. Chitin Nat Technol:209–214Google Scholar
- Haltiwanger R, Hill RL (1986) The ligand binding specificity and tissue localization of a rat alveolar macrophage lectin. J Biol Chem 261(33):15696–15702Google Scholar
- Largent B, Walton K, Hoppe CA, Lee YC, Schnaar RL (1984) Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces. J Biol Chem 259(3):1764–1769Google Scholar
- Lim YH, Tiemann KM, Hunstad DA, Elsabahy M, Wooley KL (2016) Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev: Nanomed Nanobiotechnol 8(6):842–871Google Scholar
- Nasiruddin M, Neyaz MK et al (2017) Nanotechnology-based approach in tuberculosis treatment. Tuberculosis research and treatment 2017Google Scholar
- O’brien J, Wilson I et al (2000) Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. FEBS J 267(17):5421–5426Google Scholar
- Park S, Cho J-E et al (2012) Bfl-1/A1 molecules are induced in Mycobacterium infected THP-1 cells in the early time points. J Exp Biomed Sci 18(3):201–209Google Scholar
- Patil P, Chavanke D et al (2012) A review on ionotropic gelation method: novel approach for controlled gastroretentive gelispheres. Int J Pharm Pharm Sci 4(4):27–32Google Scholar
- WHO (2017) WHO report on tuberculosis. Retrieved 1st September 2017, from http://www.who.int/mediacentre/factsheets/fs104/en/